Search research articles
Contact Us
Filters
Showing results (451-460 of 744) with videos related to
Page
of 75
Sort By:
Pigment Cell & Melanoma Research
|
December 24, 2010
A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status
Marie C Zipser, Ossia M Eichhoff, Daniel S Widmer, et al.
The Journal of Investigative Dermatology
|
October 30, 2009
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma
Sophia B Lee, Anja Schramme, Kai Doberstein, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 28, 2006
[Brief guidelines: malignant melanoma of the skin]
Claus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
International Journal of Cancer
|
September 25, 2008
Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy
Alexandr V Bazhin, Claudia Dalke, Nadine Willner, et al.
Oncoimmunology
|
August 8, 2020
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Ieva Saulite, Desislava Ignatova, Yun-Tsan Chang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 28, 2021
Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases
Marie-Luise Hilbers, Florentia Dimitriou, Peter Lau, et al.
Cell Reports. Medicine
|
June 28, 2024
Monitoring melanoma patients on treatment reveals a distinct macrophage population driving targeted therapy resistance
Jelena Vasilevska, Phil Fang Cheng, Julia Lehmann, et al.
BMC Medical Informatics and Decision Making
|
October 31, 2018
SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics
Franziska Singer, Anja Irmisch, Nora C Toussaint, et al.
Cancers
|
May 14, 2022
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma
Krisztian Homicsko, Reinhard Dummer, Christoph Hoeller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
A Phase Ib/II Study of the BRAF Inhibitor Encorafenib Plus the MEK Inhibitor Binimetinib in Patients with <i>BRAF</i> -mutant Solid Tumors
Ryan J Sullivan, Jeffrey Weber, Sapna Patel, et al.
Page
of 75
Search research articles
Search
Showing results (451-460 of 744) with videos related to
Sort By:
Page
of 75
Pigment Cell & Melanoma Research
|
December 24, 2010
A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status
Marie C Zipser, Ossia M Eichhoff, Daniel S Widmer, et al.
The Journal of Investigative Dermatology
|
October 30, 2009
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma
Sophia B Lee, Anja Schramme, Kai Doberstein, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 28, 2006
[Brief guidelines: malignant melanoma of the skin]
Claus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
International Journal of Cancer
|
September 25, 2008
Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy
Alexandr V Bazhin, Claudia Dalke, Nadine Willner, et al.
Oncoimmunology
|
August 8, 2020
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Ieva Saulite, Desislava Ignatova, Yun-Tsan Chang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 28, 2021
Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases
Marie-Luise Hilbers, Florentia Dimitriou, Peter Lau, et al.
Cell Reports. Medicine
|
June 28, 2024
Monitoring melanoma patients on treatment reveals a distinct macrophage population driving targeted therapy resistance
Jelena Vasilevska, Phil Fang Cheng, Julia Lehmann, et al.
BMC Medical Informatics and Decision Making
|
October 31, 2018
SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics
Franziska Singer, Anja Irmisch, Nora C Toussaint, et al.
Cancers
|
May 14, 2022
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma
Krisztian Homicsko, Reinhard Dummer, Christoph Hoeller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
A Phase Ib/II Study of the BRAF Inhibitor Encorafenib Plus the MEK Inhibitor Binimetinib in Patients with <i>BRAF</i> -mutant Solid Tumors
Ryan J Sullivan, Jeffrey Weber, Sapna Patel, et al.
Page
of 75